Skip to content
Aperlena

Kliniczny Szpital Wojewódzki im. św. Jadwigi Królowej w Rzeszowie

Poland Podkarpackie Public buyer Notices from 6 Jan 2026 to 12 Oct 2026

136 notices in the register, 5 open now. 55 contracts awarded, worth €125.5M in all.

Main sectors Medical equipment & pharmaceuticals 78, Software & IT systems 13, Construction work 11, Food & beverages 8, Office & computing machinery 5, Furniture & appliances 4

Record

Awards by year

  1. 2026 38 awards €98.5M
  2. 2025 6 awards €17.9M
  • €1.0M
  • €10.0M
  • largest, €14.3M
  • value not published

Each dot is one award, placed on its date and sized by its value.

Relations

Who wins with this buyer

  1. FRESENIUS MEDICAL CARE POLSKA - S.A.; Komtur Polska Sp. z o.o.; ASCLEPIOS S.A.; LEK SPÓŁKA AKCYJNA; „Farmacol- Logistyka” Sp. z o. o.; Urtica Sp. z o.o. 1 contract 2.1% €14,340,662
  2. Urtica Sp. z o.o.; CENTRALA FARMACEUTYCZNA CEFARM SA; Komtur Polska Sp. z o.o.; Sanofi Spółka z o.o; LEK SPÓŁKA AKCYJNA; Bialmed Sp. z o.o.; Janssen-Cilag Polska sp. z o.o.; AstraZeneca; Amgen Sp. z o.o.; „Farmacol- Logistyka” Sp. z o. o.; Roche Polska Sp. z o.o.; MAGNAPHARM POLAND Sp. z o.o.; ASCLE 1 contract 2.1% €10,254,535
  3. EDWARDS LIFESCIENCES POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; MEDTRONIC POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; SMT POLONIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; EFMED PRO SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ 1 contract 2.1% €9,243,991
  4. Komtur Polska Sp. z o.o.; Sanofi Spółka z o.o; Roche Polska Sp. z o.o.; Urtica Sp. z o.o.; CSL Behring Sp. z o.o.; AstraZeneca 1 contract 2.1% €9,066,311
  5. Urtica Sp. z o.o.; LEK SPÓŁKA AKCYJNA; Sanofi Spółka z o.o; AstraZeneca; ASCLEPIOS S.A.; Komtur Polska Sp. z o.o.; Janssen-Cilag Polska sp. z o.o.; Abbvie Sp. z o.o.; MEDIS farmacevtska druzba d.o.o. 1 contract 2.1% €9,065,633
  6. Medtronic Poland; Abbott Medical Sp. z.o.o; BOSTON SCIENTIFIC POLSKA; BIOTRONIK Polska Sp. z o.o; Hammermed Medical Polska Sp. z.o.o, Sp. komandytowo-akcyjna; CONMEDIC Sp z.o.o 1 contract 2.1% €7,896,471
  7. Bialmed Sp. z o.o.; ASCLEPIOS S.A.; Urtica Sp. z o.o.; Roche Polska Sp. z o.o.; „Farmacol- Logistyka” Sp. z o. o.; GSK SERVICES Sp. z o.o.; Takeda Pharma Sp. z o.o. 1 contract 2.1% €6,288,751
  8. Polimed Research Sp. z.o.o; Procardia Medical sp. z o.o.; Terumo Poland Sp. z o.o.; Teleflex Polska sp. z o.o.; Crossmed Sp. z o.o.; Rinores Sp. z o.o.; Skamex Spółka akcyjna; HAMMERMED Medical Polska Spółka z ograniczoną odpowiedzialnością Spółka komandytowo-akcyjna; Medtronic Poland Spółka z o.o.; 1 contract 2.1% €5,827,993

Shares of the 48 awards this buyer made to a named company.

Practice

How it buys

Publishing rhythm

Publishes most in March and April.

Next likely wave: March 2027.

Typical contract value
€15,414,821
Median of the last 11 priced notices

Based on 136 notices over the last 24 months.

What to expect from this buyer

Measured in its busiest sector Medical equipment & pharmaceuticals

Typical final price against the published estimate
-34.4%

Medians across the 31 comparable awards this buyer made in this sector over the last 5 years. Each figure uses the awards that publish the dates or values it needs.

Next 90 days

Coming up from this buyer

See its forecast
tenders announced in advance (last 6 months)
0
contracts due back on the market in the next 90 days
3

Scorecard

The buyer in figures

How it runs its calls for tender

usual bidding window
16 days
of its calls state an estimated value
0%

Estimates over its calls for tender of the last 3 years, bidding windows over the last 2. Deadline extensions only where the source updates a notice in place (TED publishes corrections as separate notices, so its buyers show none).

Who wins its contracts

Many suppliers
different companies won its awards
47
of the awards went to the three most frequent winners
6%
of its calls state an estimated value
0%

Based on 47 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Competition

tenders per lot on average (open and restricted procedures)
1.4
of those lots received a single tender
80%
of the awards went to companies based in another country
5%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.

Register

Tenders from this buyer

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
o
Open the result in a new tab
x
Set this result aside
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Index

Close
Log in

Language